In the rapidly evolving landscape of healthcare, genetic testing is emerging as a pivotal force, promising to transform patient care through precision medicine. The insights derived from our genetic codes hold the potential to not only prevent diseases but also optimize treatments and promote healthier living. Yet, as highlighted in a recent MedCity News article, the journey towards realizing this potential is fraught with challenges, particularly around patient privacy and data sharing.
The Role of Information Technology
A critical component in addressing these challenges is information technology security. Organizations are turning to certifications like HITRUST to establish standards for safeguarding sensitive information. By aligning with these standards, they can protect data while facilitating the sharing necessary to enhance medical knowledge and patient care.
Collaborative Efforts and Data Sharing
Collaboration is at the heart of advancing genetic testing. Companies are contributing de-identified variant data to public health databases such as ClinVAR and the SEER Cancer Registries. These efforts, supported by cancer research registries, deepen insights and expedite advancements in patient care.
The analysis of expansive data sets is crucial for understanding diseases, allowing researchers to access, assess, and test hypotheses. This collaborative approach is paving the way for tailored treatment plans and new biological discoveries, enhancing early disease detection and intervention.
Integration with Electronic Health Records
Integrating genetic testing with Electronic Health Records (EHR) is another key strategy for improving patient outcomes. Collaborations with EHR vendors like Epic, Flatiron, and Athena streamline processes, making it easier for providers to order genetic products, optimize screening protocols, and identify potential pharmacogenetic interactions. Such collaborations break down silos, enhancing data exchange for more effective research and patient care.
Challenges and Future Trends
Despite the promising progress, the integration of genetic testing into mainstream medicine presents challenges, including managing the vast volume of genomic data. Companies are focusing on presenting complex clinical interpretations, integrating common data ontologies, overcoming data fragmentation, and ensuring data privacy to address these hurdles.
Looking ahead, the industry anticipates significant advancements, with trends like developing tests for early cancer recurrence detection and embracing a multi-omics approach that integrates RNA, proteins, and AI insights. The integration of generative AI for documentation and genetic counseling is another notable development on the horizon.
A New Era in Healthcare
Genetic testing represents more than just a scientific advancement; it signifies a fundamental shift in how we approach health and wellness. As public understanding grows and technology advances, we find ourselves at the dawn of a new era in healthcare, where our genetic code becomes a roadmap to better health and longevity.
About the Author
Kevin Haas, Ph.D., serves as the Chief Technology Officer at Myriad Genetics, where he leads the development of the precision medicine platform. With expertise in molecular simulation and machine learning, Haas is advancing genomics and digital patient/provider experiences. He has co-authored 16 peer-reviewed publications and nine patent applications, bringing a wealth of experience to his role.
More Articles
Getting licensed or staying ahead in your career can be a journey—but it doesn’t have to be overwhelming. Grab your favorite coffee or tea, take a moment to relax, and browse through our articles. Whether you’re just starting out or renewing your expertise, we’ve got tips, insights, and advice to keep you moving forward. Here’s to your success—one sip and one step at a time!
Florida homeowners — especially in hard‑hit South Florida — are set to see rare and substantial reductions in their property insurance premiums. Gov. Ron DeSantis announced an average statewide Citizens Insurance decrease of 8.7%, with even larger savings of up to 14% in counties like Miami-Dade, Broward, and Palm Beach. State officials credit recent legal and regulatory reforms for stabilizing the market, attracting new insurers, and delivering the first meaningful rate relief Floridians have seen in years.
Tampa’s commercial real estate market isn’t slowing—it’s maturing. With strong population growth, rising office demand, a normalized industrial sector, resurgent retail, and an emerging health‑care real estate boom, investors are shifting from speed to strategy. Tighter underwriting, cautious capital and increased due‑diligence are shaping a more disciplined market, creating new opportunities for informed professionals.
Florida homeowners are finally seeing relief as Citizens Property Insurance announces a major 8.7% average rate decrease—far larger than originally proposed. Driven by legislative reforms, fewer lawsuits, and a calm hurricane season, the state’s once‑unstable insurance market is showing real signs of recovery. But with reduced coverage limits and shifting legal protections, experts warn that lower premiums may come with hidden trade‑offs.
After a decade of rising premiums and retreating carriers, Florida homeowners are finally seeing long‑awaited relief. Dozens of insurers have filed for rate decreases—some as high as 11%—thanks to legislative reforms and a stabilizing market. Early approvals are already hitting counties across the state, and experts say the momentum could boost buyer confidence, affordability, and competition throughout Florida’s real estate and insurance sectors.
After years of slowed activity caused by rising interest rates, the self‑storage industry is heating up again. New data from Marcus & Millichap shows a fresh market cycle emerging, driven by renewed buyer confidence, recalibrated pricing, and stronger lender participation. Acquisitions are rebounding, development is resetting in a healthier direction, and financing conditions are improving—creating one of the most promising investment landscapes the sector has seen in years.
Brookline’s newly updated FEMA flood maps identify 97 high‑risk parcels, but local experts warn the true threat is far greater. While FEMA highlights river‑based flooding around Leverett Pond and the Muddy River, alternative models show more than 1,300 Brookline properties at risk within 30 years. Hidden vulnerabilities along major corridors like Beacon Street, rising rainfall intensity, aging infrastructure, and climate‑driven storm patterns suggest that many “low‑risk” areas may be anything but safe.
